A detailed history of Rayliant Investment Research transactions in Invitae Corp stock. As of the latest transaction made, Rayliant Investment Research holds 50,388 shares of NVTA stock, worth $0. This represents 0.09% of its overall portfolio holdings.

Number of Shares
50,388
Holding current value
$0
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $86,163 - $181,900
50,388 New
50,388 $93.7 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Rayliant Investment Research Portfolio

Follow Rayliant Investment Research and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rayliant Investment Research, based on Form 13F filings with the SEC.

News

Stay updated on Rayliant Investment Research with notifications on news.